3gef: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
[[Image:3gef.png|left|200px]] | |||
[[Image:3gef. | |||
{{STRUCTURE_3gef| PDB=3gef | SCENE= }} | {{STRUCTURE_3gef| PDB=3gef | SCENE= }} | ||
===Crystal structure of the R482W mutant of lamin A/C=== | ===Crystal structure of the R482W mutant of lamin A/C=== | ||
{{ABSTRACT_PUBMED_19574635}} | {{ABSTRACT_PUBMED_19574635}} | ||
==About this Structure== | ==About this Structure== | ||
[[3gef]] is a 4 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3GEF OCA]. | |||
==Reference== | ==Reference== | ||
<ref group="xtra">PMID: | <ref group="xtra">PMID:019574635</ref><references group="xtra"/> | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Kozlov, S.]] | [[Category: Kozlov, S.]] | ||
Line 30: | Line 18: | ||
[[Category: Wlodawer, A.]] | [[Category: Wlodawer, A.]] | ||
[[Category: Zdanov, A.]] | [[Category: Zdanov, A.]] | ||
[[Category: Cardiomyopathy]] | [[Category: Cardiomyopathy]] | ||
[[Category: Charcot-marie-tooth disease]] | [[Category: Charcot-marie-tooth disease]] | ||
[[Category: Disease mutation]] | [[Category: Disease mutation]] | ||
[[Category: Immunoglobulin fold]] | [[Category: Immunoglobulin fold]] | ||
Line 45: | Line 30: | ||
[[Category: Prenylation]] | [[Category: Prenylation]] | ||
[[Category: Structural protein]] | [[Category: Structural protein]] | ||
Revision as of 17:26, 20 February 2013
Crystal structure of the R482W mutant of lamin A/CCrystal structure of the R482W mutant of lamin A/C
Template:ABSTRACT PUBMED 19574635
About this StructureAbout this Structure
3gef is a 4 chain structure with sequence from Homo sapiens. Full crystallographic information is available from OCA.
ReferenceReference
- ↑ Magracheva E, Kozlov S, Stewart CL, Wlodawer A, Zdanov A. Structure of the lamin A/C R482W mutant responsible for dominant familial partial lipodystrophy (FPLD). Acta Crystallogr Sect F Struct Biol Cryst Commun. 2009 Jul 1;65(Pt, 7):665-70. Epub 2009 Jun 27. PMID:19574635 doi:10.1107/S1744309109020302